Quality is Life — Laos Alliance Pharmaceutical Group

ລາວ/中文/EN

Become a partner
Manufacturing & innovation
Manufacturing Capabilities
Every dosage form we make
Manufacturing Capabilities
Manufacturing Network
Plants & 20 workshops
Manufacturing Network
Research & Development
Labs, ATMP & formulation
Research & Development
Quality & GMP
Standards & traceability
Quality & GMP
Alliance Regenerative Centre
Stem-cell, NK & exosome science
Alliance Regenerative Centre
Integrated Value Chain
Farm → chemicals → finished
Integrated Value Chain
What we make
Every major dosage form, made to one GMP standard
Explore capabilities
Explore capabilities
ALILUTRBOPA
Rx
Cancer & Blood Disorders

ALILUTRBOPA

Lusutrombopag
Generic (INN)
Lusutrombopag
Strength
3mg
Packaging
7 tablets/blister · 1 blister/box
Indication
Raises low platelets before a procedure in chronic liver disease. (See package insert.)
Registration No.
06-LM-10030-26
Package Insert
English & Lao (PDF)

More in Cancer & Blood Disorders

View all →
ALIIBRU
ALIIBRU
Ibrutinib
ALILAZTINI
ALILAZTINI
Lazertinib
ALIREVMENI 160mg
ALIREVMENI 160mg
Revumenib citrate
ALIALPELISIB
ALIALPELISIB
Alpelisib
About AllianceLeadershipVision & MissionHistoryGroup StructureOur ResponsibilityCertifications & Licenses
PharmaceuticalsAlliance Regenerative CentreAnimal HealthSupplementsCosmeticsHousehold & HygieneChemicalsMedical DevicesBrowse all products →
Manufacturing & Innovation overviewManufacturing CapabilitiesManufacturing NetworkResearch & DevelopmentQuality & GMPIntegrated Value ChainAlliance Regenerative Centre
Business Solutions overviewContract ManufacturingPrivate LabelDistributionGovernment & InstitutionalInternational PartnershipsBecome a PartnerPartnerships
Company NewsInvestmentsEventsPress ReleasesProduct Safety
ContactLocationsCareers
Become a partner
EN·ລາວ·中文